No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business

Patients hoping for a new alternative to the blockbuster blood thinner Plavix will have to wait a bit longer for a verdict on a promising candidate.

Read more »

FDA to Collaborate with Pharma Companies on New TB Initiative

A number of pharmaceutical companies will collaborate with FDA scientists to test new TB combination therapies and identify promising candidates.

Read more »

ImmunoGen Signs 2nd Licensing Deal with Amgen

ImmunoGen has licensed its anti-cancer technology to Amgen for an upfront payment of $1 million.

Read more »

Burrill Report: Biotech Innovation Gets the Cash

If the past week is any indication, big pharma is showing that it is willing to pay for biotech innovation.

Read more »

Micromet Signs $477M Deal with Sanofi-Aventis

Micromet has licensed one of its cancer-fighting antibody candidates to Sanofi-Aventis in a $477 million deal.

Read more »

Unilife: Medical Device Innovator Creating Jobs in PA

Unilife Medical Solutions is an emerging medical device manufacturer with business segments that include pre-filled syringes for pharmaceutical companies to deliver injectable medications, sharps safety devices for healthcare facilities, and contract manufacturing of medical devices.

Read more »

First Swine Flu Vaccines Approved

The U.S. government has approved swine flu vaccines from four pharmaceutical companies, Reuters reports.

Read more »

Fall Allergy Season Is Upon Us

Ragweed season is under way, bringing with it sneezes, sniffles, and itchy eyes for 36 million Americans.

Read more »